Newsroom

NEW POLL: Majority of Americans Support Lower Drug Prices, Demand Congress Act
04.22.2025
Lower Federal Spending by Cutting Unnecessary Health Care Costs, Not Coverage
04.07.2025
Inclusion of Billing Transparency and Patent Reform in End-of-Year Spending Package a Win for Americans
12.17.2024
Arnold Ventures Optimistic Upon Seeing the First Round of Medicare Negotiated Drug Prices Announced
08.15.2024
Arnold Ventures Commends Senate on Unanimous Passage of the Affordable Prescriptions for Patients Act
07.11.2024
New Law Goes Into Effect to Strengthen The Maryland Prescription Drug Affordability Board
04.11.2023
California Selects Civica Rx as Its Insulin Manufacturing Partner
03.20.2023
Statement from Laura and John Arnold on Landmark Law to Lower Prescription Drug Prices
08.16.2022
Statement from Laura and John Arnold Following Senate Passage of the Inflation Reduction Act of 2022
08.07.2022
“It’s time to finish the job.”: Statement from Mark E. Miller on Historic Opportunity for Congress to Lower Prescription Drug Prices
06.30.2022
Statement from Mark E. Miller on New Insulin Legislation Offered in Senate
06.23.2022
Arnold Ventures’ Statement on the Removal of Drug Pricing from the Build Back Better Framework
10.28.2021

Media Inquiries

If you are a member of the media, contact us via email at media@arnoldventures.org. Please include your name, media outlet affiliation, contact information, questions, and deadline.